LINDSEY SENN: Open Payments
NPI 1447768734 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$906 in 44 payments from 10 companies in 2025. Trend: 2023 $137 · 2024 $724 · 2025 $906
Food & beverage: $906
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $305 |
| Janssen Biotech, Inc. | 10 | $213 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $101 |
| Janssen Scientific Affairs, LLC | 1 | $92 |
| PFIZER INC. | 3 | $54 |
| Lilly USA, LLC | 2 | $50 |
| Ardelyx, Inc. | 2 | $30 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
| Celltrion USA Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 2 | $16 |
Products named: TREMFYA, RINVOQ, ENTYVIO, OMVOH, XELJANZ, IBSRELA, UPTRAVI, VEGZELMA.
Industry payments across KY — which companies pay providers there.
